Scribe Therapeutics Inc. (SCTX)
NASDAQ: SCTX · Real-Time Price · USD
20.76
-0.89 (-4.11%)
Jul 27, 2026, 9:44 AM EDT - Market open
Scribe Therapeutics Employees
Scribe Therapeutics had 89 employees as of March 31, 2026. The number of employees did not change since the number was last reported on December 31, 2025.
Employees
89
Change
n/a
Growth
n/a
Revenue / Employee
$407,663
Profits / Employee
-$401,461
Market Cap
365.63M
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Mar 31, 2026 | 89 | 0 | - |
| Dec 31, 2025 | 89 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| Valneva SE | 674 |
| ProKidney | 231 |
| Cabaletta Bio | 158 |
| Kyverna Therapeutics | 129 |
| Ocugen | 116 |
| Cybin | 100 |
| Larimar Therapeutics | 71 |
| Prothena Corporation | 67 |
SCTX News
- 2 days ago - Scribe Therapeutics opens at $25, IPO priced at $15 per share - TheFly
- 2 days ago - Scribe Therapeutics indicated to open at $25, IPO priced at $15 per share - TheFly
- 2 days ago - Scribe Therapeutics indicated to open at $29.20, IPO priced at $15 per share - TheFly
- 3 days ago - Scribe Therapeutics 8.58M share IPO priced at $15.00 - TheFly
- 3 days ago - Scribe Therapeutics Announces Pricing of Upsized Initial Public Offering - GlobeNewsWire
- 24 days ago - Scribe Therapeutics IPO Registration Document (S-1) - SEC
- 24 days ago - Cardiovascular diseases biotech Scribe Therapeutics files for a $75 million IPO - Renaissance Capital